NHS Long Term Plan take-outs for the life science industry

1024 575 Admin

There is a lot in the NHS Long Term Plan that will provide opportunities and challenges for the life science industry, both strategically across the NHS and disease/therapy-focused. See our…

read more

‘State of the relationship’ survey

433 106 Admin

Does the NHS want to work in partnership with the life science industry?  Does the industry have the capabilities to partner with the NHS?  It’s time to have your say…

read more

“Navigating the complexities of market access in Europe” workshop with Visions4Health and HCA – 8th November 2018

363 213 Admin

Following the recent success of our “Navigating the complexities of Market Access in Europe” workshop with the Healthcare Communications Association (HCA), we are providing another opportunity for you to get…

read more

Visions4Health team up with the PM Society to provide “UK market access fundamentals” workshop – November 2018

484 293 Admin

  This interactive 1-day course is designed for both pharmaceutical and agency staff who are relatively new to UK market access or for those who want to move to a…

read more

Integrated care systems: What are the implications for the life science industry?

1024 573 Admin

Many of our life-science clients are asking about engagement with local health-system leaders. Particularly, where to focus, when to engage and how to partner. Some have instructed their field teams…

read more

How can the life science industry improve the impact of face-to-face interactions with customers?

1024 685 Admin

Currently the life-science industry’s promotional model remains disproportionately focussed on the clinical sell. It’s questionable how effective this is and pharma and devices companies continue to grapple with optimising their…

read more

NICE says ‘yes’ to first overseas treatment on the NHS

911 601 Admin

NICE guidance recommends treatment delivered in Italy to be funded by the NHS National Institute for Health and Care Excellence (NICE) has released guidance recommending gene therapy for rare disease…

read more

New NHS planning guidance for England: Refreshing NHS plans for 2018/19

911 601 Admin

Context: The additional NHS funding of £1.6 billion announced in the November 2017 budget and a further £540 million released by the Department of Health & Social Care is being…

read more

An update on Regional Medicines Optimisation Committees (RMOCs)

1024 683 Admin

Four Regional Medicines Optimisation Committees (RMOCs) for England (London, North, South and Midlands & East) formally came into being in 2017. Their role: to provide advice and make recommendations on…

read more